NorthWest Biotherapeutics Inc (NWBO)

[iclight]

I find your thinking that this crap works amusing. Any oncologist comparing the interim blended data to the final data would give their patients whatever the placebo arm got patients lived longer. And nobody aside from the imbecile longs here who don't understand ORR and bears here that do has ever heard of Direct. Bosch said after the Direct trial that patients with SD live longer. No crap, that's true for untreated patients too and certainly not what any biotech wants to see in a cancer trial with ORR as an endpoint.